title: Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
abstract: OBJECTIVE
  The objectives of this article are to review the new Response Evaluation Criteria in Solid Tumors (RECIST) guideline, version 1.1, highlighting the major changes in the new version compared with the original RECIST guideline (version 1.0), and to present case examples with representative imaging.
  
  
  CONCLUSIONS
  Familiarity with the revised RECIST is essential in day-to-day oncologic imaging practice to provide up-to-date service to oncologists and their patients. Some of the changes in the revised RECIST affect how radiologists select, measure, and report target lesions.
authors.affiliation: Department of Imaging, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Mizuki_Nishino@dfci.harvard.edu
authors.forename: Mizuki
authors.initials: M
authors.lastname: Nishino
authors.forename: Jyothi P
authors.initials: JP
authors.lastname: Jagannathan
authors.forename: Nikhil H
authors.initials: NH
authors.lastname: Ramaiya
authors.forename: Annick D
authors.initials: AD
authors.lastname: Van den Abbeele
mesh_terms: D003952:Diagnostic Imaging / Q000592:standards*; D019983:Guideline Adherence; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D017410:Practice Guidelines as Topic; D011871:Radiology / Q000592:standards*; D014481:United States